Coromandel International expects healthy demand and consequently good volumes in the coming season. In an interview with CNBC-TV18, Kapil Mehan, MD of Coromandel International said that the company has entered a contract for phosphoric acid valued at $850. The company also expects to improve production levels by 30-40%, added Mehan.
first published: May 18, 2012 01:52 pm
A collection of the most-viewed Moneycontrol videos.
Point-to-Point vs Rolling Returns for Mutual Funds: Full Breakdown
From Hesitant Heir to Undisputed Leader: Sanjiv Bajaj's Leadership Story
Nifty Fails To Defend 26,000 Amid Sluggish Start To Final Week Of 2025| Closing Bell Live
Nifty Aims To Defend 26,000 Amid Thin Volumes, Record-Low VIX| Opening Bell Live
